ArticleScientific reports2024

A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.

Shanshan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.